Connect with us

Home

Is It Time To Buy Cannabis Stocks?

As a stock investor, it has been impossible to miss the wild volatility of the Cannabis sector in 2018.  So is it time to buy these companies?  I have two words for you – Inevitability and Optionality.
 
First, some perspective is in order, lookin…

Published

on

Is It Time To Buy Cannabis Stocks?

As a stock investor, it has been impossible to miss the wild volatility of the Cannabis sector in 2018.  So is it time to buy these companies?  I have two words for you – Inevitability and Optionality.

 

First, some perspective is in order, looking just at overall performance for 2018 misses the drama of what occurred in 2018.  This past year saw wild gains up to around the time of legalization of recreational marijuana in Canada and then a painful selloff. 

Continue reading Is It Time To Buy Cannabis Stocks? at The Blunt Investor.

Continue Reading

Canada

Canadian L.P.’s Still Lead

Canadian cannabis LPs are looking to be in a good position on the global stage. Marijuana’s momentum is rising worldwide, as many countries legalise and develop medical cannabis programs. Many expect the trend to continue in 2019, and Canadian producer…

Published

on

Canadian L.P.’s Still Lead

Canadian cannabis LPs are looking to be in a good position on the global stage. Marijuana’s momentum is rising worldwide, as many countries legalise and develop medical cannabis programs. Many expect the trend to continue in 2019, and Canadian producers are ready. More

Continue reading Canadian L.P.’s Still Lead at The Blunt Investor.

Continue Reading

Canada

Canopy Expanding to the U.S.

Canopy Growth Corp. secured a New York state license to produce and process hemp there, according to an announcement early this week. The company said they intend to invest between US$100m-US$150m in a hemp extraction and manufacturing facility, and sh…

Published

on

Canopy Expanding to the U.S.

Canopy Growth Corp. secured a New York state license to produce and process hemp there, according to an announcement early this week. The company said they intend to invest between US$100m-US$150m in a hemp extraction and manufacturing facility, and shareholders took well to the news. More

Continue reading Canopy Expanding to the U.S. at The Blunt Investor.

Continue Reading

Auroa Cannabis Inc

Aurora Cannabis to Offer More Organics with Acquisition

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) shares enjoyed a nearly 6% pop in price in today’s trading after the company announced the completion of a letter of intent with Whistler Medical Marijuana Corporation. The Edmonton-based cannabis company wil…

Published

on

Aurora Cannabis to Offer More Organics with Acquisition

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) shares enjoyed a nearly 6% pop in price in today’s trading after the company announced the completion of a letter of intent with Whistler Medical Marijuana Corporation. The Edmonton-based cannabis company will acquire all the issued and outstanding shares of Whistler in an all stock deal. More

Continue reading Aurora Cannabis to Offer More Organics with Acquisition at The Blunt Investor.

Continue Reading

Trending